FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer-Reference-Cited by-同舟云学术

FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer

Published:2019-03-12 Issue:8 Volume:24 Page:927-933
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Jingu Keiichi^ORCID,Umezawa Rei,Yamamoto Takaya,Takeda Kazuya,Ishikawa Yojiro,Takahashi Noriyoshi,Kadoya Noriyuki,Matsushita Haruo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01428-8.pdf

Reference11 articles.

1. Ferlay J, Soerjomataram I, Ervik M et al (2012) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer (IARC), Lyon

2. Barber TW, Duong CP, Leong T et al (2012) 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. J Nucl Med 53(6):864–871

3. Wong R, Walker-Dilks C, Raifu A (2012) Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer. Clin Oncol (R Coll Radiol) 24(2):86–104

4. Katsoulis IE, Wong WL, Mattheou AK et al (2007) Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study. Int J Surg 5(6):399–403

5. Gillies RS, Middleton MR, Maynard ND et al (2011) Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer. Eur Radiol 21(2):274–280

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy;Radiation Oncology;2023-02-24

2. SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer;Frontiers in Genetics;2022-05-18

3. Surgical strategies for treatment of clinical T4 esophageal cancer in Japan;Global Health & Medicine;2021-12-31

4. Associations of postoperative recurrence of esophageal cancer with changes in inflammatory factors, insulin resistance and intestinal flora;Panminerva Medica;2021-06

5. Dynamic contrast-enhanced magnetic resonance imaging: A novel approach to assessing treatment in locally advanced esophageal cancer patients;Nigerian Journal of Clinical Practice;2021